BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04191096-completion@plaintrial.com
DTSTAMP:20261027T125010Z
DTSTART;VALUE=DATE:20260327
SUMMARY:Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Pl
 us Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plu
 s ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (m
 HSPC) (MK-3475-991/KEYNOTE-991) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04191096
URL:https://plaintrial.com/trial/NCT04191096
END:VEVENT
END:VCALENDAR